WT1 and biliary tract cancer: WT1 mutations are present in 68%-80% of biliary tract cancers, and while the clinical relevance in biliary tract cancer is still under investigation, similar mutations have been associated with poor prognosis in other cancers like testicular, breast, and head and neck cancers (48).